Structure-based virtual screening of chemical libraries for drug discovery

Area of Science:

• Computational chemistry and cheminformatics
• Drug discovery and development
• Molecular modeling and simulation

Background:

• Identifying novel chemical entities with high target-binding affinity is crucial for drug discovery.
• Virtual screening (VS) is increasingly employed to enhance the efficiency of drug discovery pipelines.
• Advances in high-performance computing have significantly boosted the capabilities and scope of VS.

Purpose of the Study:

• To highlight the role of virtual screening as a complementary technique in modern drug discovery.
• To underscore the impact of computational power on the evolution of virtual screening methodologies.
• To showcase the successful application of VS across diverse biological targets.

Main Methods:

• Utilizing virtual screening techniques to analyze large chemical databases.
• Employing high-performance computing resources for accelerated screening processes.
• Focusing on identifying molecular interactions between small molecules and protein targets.

Main Results:

• Successful screening of extensive chemical libraries has been achieved.
• Identification of potential drug candidates ('hits') for a wide array of protein targets.
• Demonstrated efficacy of VS in diverse therapeutic areas.

Conclusions:

• Virtual screening is a powerful and evolving tool in accelerating the identification of drug leads.
• The integration of VS with high-throughput screening optimizes the drug discovery and development process.
• VS enables the exploration of vast chemical spaces for targets including kinases, proteases, and receptors.